0

Close
 
Upcoming Allied Market Research
2023
Female Sterilization Procedures Market

Female Sterilization Procedures Market

by Procedure Type (Surgical, Non-surgical, Others) and by End User (Hospitals, Ambulatory centers, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Healthcare IT
Report Code: A11426
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Female Sterilization Procedures Market

Request Now !

Female Sterilization Procedures Market Outlook 2027

The female sterilization is the procedure performed to prevent pregnancy. In this procedure, the fallopian tube is blocked to prevent the egg from reaching the uterus. This also avoids the meeting of sperm and egg. This is achieved in the females who desire not to be pregnant. This is a good option for the birth control. There are two types of female sterilization. They are surgical and non-surgical sterilization. Surgical female sterilization is the tubal ligation technique where the fallopian tube is cut and sealed. This is achieved with the help minimally invasive surgery technique named laparoscopy. It can be done just after the C-section technique. This technique shows its effect immediately after the surgery. The non-surgical female sterilization is a technique which uses the various devices are placed into the fallopian tube to seal them. Actually, these devices are inserted through the vagina and uterus without any incision in the body parts. This procedure requires approximately three months to show its effect. The procedure has various advantages like it avoids the side effects that can be seen in birth control pills, intrauterine devices. It may also lower the risk of ovarian cancer. However, it also has some of the disadvantages like it is an irreversible procedure although some techniques can be reversed but the results may not work fine. It offers zero protection against sexually transmitted diseases.


COVID-19 Scenario Analysis: 

Coronavirus disease 2019 (COVID-19) has created an economic crisis along with a healthcare crisis. COVID-19 pandemic has stretched healthcare system worldwide, developed countries are expected to cause economic recession. The Covid-19 pandemic has an adverse impact on the healthcare system, resulting in 50% to 70% drop in revenue from March. Many small hospitals, clinics and nursing homes, have been forced to shut their operations. As a result of social distancing and localized curfews have resulted in delayed elective surgical procedures. In addition, visa cancellations have led to a hiatus in medical tourism and can negatively impact the healthcare services female sterilization procedure market growth. 

Top impacting factors: Market Scenario Analysis, Trends, Drivers, Impact Analysis

The increase in the demand or desire for the female sterilization procedure with utmost safety and effectiveness, technological advancements in the devices and the procedures and increase in healthcare expenditure is expected to increase the growth of the market. Furthermore, increase in awareness among people about sterilization procedures and collaborations of the emerging market players can provide the opportunity for the players in the female sterilization procedures market. 

However, high cost of the female sterilization surgical or non-surgical procedures, lack of safety feature, problems of availability of female sterilization procedure center in the remote areas and cultural acceptability problems of this procedures are expected to hamper the growth of the female sterilization procedures market.

New product launches to flourish the market:

In February 2018, Teleflex Medical, Inc., received the 510(k) clearance for the product Teleflex Minilap System with Minigrip Bipolar Handle by the U.S.FDA.

In November 2019, Dannik LLC, received the 510(k) clearance for the product Dannik Laparoscopic Suction Irrigation system by the U.S.FDA. 

Surge in the usage of the female sterilization procedures:

Increase in demand and desire of female sterilization and availability of these procedure centers are expected to increase the usage of the female sterilization procedures. In addition, increase in awareness of devices and advertising aids can also help to surge the usage of the female sterilization procedures.

Key benefits of the report:

  • This study presents the analytical depiction of the global female sterilization procedures industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global female sterilization procedures market share.
  • The current market is quantitatively analyzed to highlight the global female sterilization procedures market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global female sterilization procedures market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the female sterilization procedure market research report:

  • What are the leading market players active in the female sterilization procedure market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

 Female Sterilization Procedures Market Report Highlights

Aspects Details
By Procedure Type
  • Surgical
  • Non-surgical
  • Others
By End User
  • Hospitals
  • Ambulatory centers
  • Clinics
  • Others
By Region
  • North America 
  • Europe 
  • Asia-Pacific 
  • Latin America 
  • The Middle East and Africa 
American Medical Systems Inc., Bayer AG, B. Braun Melsungen AG, Becton, Dickinson and Company, Cardinal Health Inc., Conceptus Inc., Conmed Corporation, Ethicon Inc., Hologic Inc., Medtronic plc., others.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: FEMALE STERILIZATION PROCEDURES MARKET, BY PROCEDURE TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Procedure Type

    • 4.2. Surgical

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Non-surgical

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Others

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: FEMALE STERILIZATION PROCEDURES MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Ambulatory Centers

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Clinics

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: FEMALE STERILIZATION PROCEDURES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Procedure Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Female Sterilization Procedures Market

        • 6.2.5.1. Market Size and Forecast, By Procedure Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Female Sterilization Procedures Market

        • 6.2.6.1. Market Size and Forecast, By Procedure Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Female Sterilization Procedures Market

        • 6.2.7.1. Market Size and Forecast, By Procedure Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Procedure Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Female Sterilization Procedures Market

        • 6.3.5.1. Market Size and Forecast, By Procedure Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Female Sterilization Procedures Market

        • 6.3.6.1. Market Size and Forecast, By Procedure Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Female Sterilization Procedures Market

        • 6.3.7.1. Market Size and Forecast, By Procedure Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Female Sterilization Procedures Market

        • 6.3.8.1. Market Size and Forecast, By Procedure Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Female Sterilization Procedures Market

        • 6.3.9.1. Market Size and Forecast, By Procedure Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Female Sterilization Procedures Market

        • 6.3.10.1. Market Size and Forecast, By Procedure Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Female Sterilization Procedures Market

        • 6.3.11.1. Market Size and Forecast, By Procedure Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Procedure Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Female Sterilization Procedures Market

        • 6.4.5.1. Market Size and Forecast, By Procedure Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Female Sterilization Procedures Market

        • 6.4.6.1. Market Size and Forecast, By Procedure Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Female Sterilization Procedures Market

        • 6.4.7.1. Market Size and Forecast, By Procedure Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Female Sterilization Procedures Market

        • 6.4.8.1. Market Size and Forecast, By Procedure Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Female Sterilization Procedures Market

        • 6.4.9.1. Market Size and Forecast, By Procedure Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Female Sterilization Procedures Market

        • 6.4.10.1. Market Size and Forecast, By Procedure Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Female Sterilization Procedures Market

        • 6.4.11.1. Market Size and Forecast, By Procedure Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Female Sterilization Procedures Market

        • 6.4.12.1. Market Size and Forecast, By Procedure Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Female Sterilization Procedures Market

        • 6.4.13.1. Market Size and Forecast, By Procedure Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Procedure Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Female Sterilization Procedures Market

        • 6.5.5.1. Market Size and Forecast, By Procedure Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Female Sterilization Procedures Market

        • 6.5.6.1. Market Size and Forecast, By Procedure Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Female Sterilization Procedures Market

        • 6.5.7.1. Market Size and Forecast, By Procedure Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Female Sterilization Procedures Market

        • 6.5.8.1. Market Size and Forecast, By Procedure Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Female Sterilization Procedures Market

        • 6.5.9.1. Market Size and Forecast, By Procedure Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Female Sterilization Procedures Market

        • 6.5.10.1. Market Size and Forecast, By Procedure Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Company 1

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Company 2

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Company 3

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Company 4

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Company 5

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Company 6

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Company 7

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Company 8

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Company 9

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Company 10

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET FOR SURGICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET FOR NON-SURGICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET FOR AMBULATORY CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA FEMALE STERILIZATION PROCEDURES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 14. U.S. FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 15. U.S. FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. CANADA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 17. CANADA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. MEXICO FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 19. MEXICO FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE FEMALE STERILIZATION PROCEDURES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. FRANCE FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. GERMANY FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. ITALY FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 28. ITALY FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. SPAIN FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. UK FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 32. UK FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. RUSSIA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 34. RUSSIA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. REST OF EUROPE FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC FEMALE STERILIZATION PROCEDURES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. CHINA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 41. CHINA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. JAPAN FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 43. JAPAN FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. INDIA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 45. INDIA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. SOUTH KOREA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 47. SOUTH KOREA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. AUSTRALIA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 49. AUSTRALIA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. THAILAND FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 51. THAILAND FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. MALAYSIA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 53. MALAYSIA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. INDONESIA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 55. INDONESIA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA FEMALE STERILIZATION PROCEDURES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 59. LAMEA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. BRAZIL FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 62. BRAZIL FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH AFRICA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. SAUDI ARABIA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 66. SAUDI ARABIA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. UAE FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 68. UAE FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. ARGENTINA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 70. ARGENTINA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. REST OF LAMEA FEMALE STERILIZATION PROCEDURES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 72. REST OF LAMEA FEMALE STERILIZATION PROCEDURES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. COMPANY 1: KEY EXECUTIVES
  • TABLE 74. COMPANY 1: COMPANY SNAPSHOT
  • TABLE 75. COMPANY 1: OPERATING SEGMENTS
  • TABLE 76. COMPANY 1: PRODUCT PORTFOLIO
  • TABLE 77. COMPANY 1: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. COMPANY 2: KEY EXECUTIVES
  • TABLE 79. COMPANY 2: COMPANY SNAPSHOT
  • TABLE 80. COMPANY 2: OPERATING SEGMENTS
  • TABLE 81. COMPANY 2: PRODUCT PORTFOLIO
  • TABLE 82. COMPANY 2: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. COMPANY 3: KEY EXECUTIVES
  • TABLE 84. COMPANY 3: COMPANY SNAPSHOT
  • TABLE 85. COMPANY 3: OPERATING SEGMENTS
  • TABLE 86. COMPANY 3: PRODUCT PORTFOLIO
  • TABLE 87. COMPANY 3: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. COMPANY 4: KEY EXECUTIVES
  • TABLE 89. COMPANY 4: COMPANY SNAPSHOT
  • TABLE 90. COMPANY 4: OPERATING SEGMENTS
  • TABLE 91. COMPANY 4: PRODUCT PORTFOLIO
  • TABLE 92. COMPANY 4: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. COMPANY 5: KEY EXECUTIVES
  • TABLE 94. COMPANY 5: COMPANY SNAPSHOT
  • TABLE 95. COMPANY 5: OPERATING SEGMENTS
  • TABLE 96. COMPANY 5: PRODUCT PORTFOLIO
  • TABLE 97. COMPANY 5: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. COMPANY 6: KEY EXECUTIVES
  • TABLE 99. COMPANY 6: COMPANY SNAPSHOT
  • TABLE 100. COMPANY 6: OPERATING SEGMENTS
  • TABLE 101. COMPANY 6: PRODUCT PORTFOLIO
  • TABLE 102. COMPANY 6: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. COMPANY 7: KEY EXECUTIVES
  • TABLE 104. COMPANY 7: COMPANY SNAPSHOT
  • TABLE 105. COMPANY 7: OPERATING SEGMENTS
  • TABLE 106. COMPANY 7: PRODUCT PORTFOLIO
  • TABLE 107. COMPANY 7: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. COMPANY 8: KEY EXECUTIVES
  • TABLE 109. COMPANY 8: COMPANY SNAPSHOT
  • TABLE 110. COMPANY 8: OPERATING SEGMENTS
  • TABLE 111. COMPANY 8: PRODUCT PORTFOLIO
  • TABLE 112. COMPANY 8: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. COMPANY 9: KEY EXECUTIVES
  • TABLE 114. COMPANY 9: COMPANY SNAPSHOT
  • TABLE 115. COMPANY 9: OPERATING SEGMENTS
  • TABLE 116. COMPANY 9: PRODUCT PORTFOLIO
  • TABLE 117. COMPANY 9: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. COMPANY 10: KEY EXECUTIVES
  • TABLE 119. COMPANY 10: COMPANY SNAPSHOT
  • TABLE 120. COMPANY 10: OPERATING SEGMENTS
  • TABLE 121. COMPANY 10: PRODUCT PORTFOLIO
  • TABLE 122. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL FEMALE STERILIZATION PROCEDURES MARKET
  • FIGURE 3. SEGMENTATION FEMALE STERILIZATION PROCEDURES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN FEMALE STERILIZATION PROCEDURES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALFEMALE STERILIZATION PROCEDURES MARKET
  • FIGURE 11. FEMALE STERILIZATION PROCEDURES MARKET SEGMENTATION, BY PROCEDURE TYPE
  • FIGURE 12. FEMALE STERILIZATION PROCEDURES MARKET FOR SURGICAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. FEMALE STERILIZATION PROCEDURES MARKET FOR NON-SURGICAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. FEMALE STERILIZATION PROCEDURES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. FEMALE STERILIZATION PROCEDURES MARKET SEGMENTATION, BY END USER
  • FIGURE 16. FEMALE STERILIZATION PROCEDURES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. FEMALE STERILIZATION PROCEDURES MARKET FOR AMBULATORY CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. FEMALE STERILIZATION PROCEDURES MARKET FOR CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. FEMALE STERILIZATION PROCEDURES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: FEMALE STERILIZATION PROCEDURES MARKET
  • FIGURE 26. Top player positioning, 2022
  • FIGURE 27. COMPANY 1: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. COMPANY 1: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. COMPANY 1: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. COMPANY 2: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. COMPANY 2: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. COMPANY 2: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. COMPANY 3: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. COMPANY 3: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. COMPANY 3: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. COMPANY 4: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. COMPANY 4: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. COMPANY 4: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. COMPANY 5: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. COMPANY 5: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. COMPANY 5: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. COMPANY 6: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. COMPANY 6: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. COMPANY 6: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. COMPANY 7: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. COMPANY 7: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. COMPANY 7: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. COMPANY 8: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. COMPANY 8: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. COMPANY 8: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. COMPANY 9: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. COMPANY 9: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. COMPANY 9: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. COMPANY 10: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. COMPANY 10: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Female Sterilization Procedures Market

Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers